Marlene Vincent

Marlene Vincent is an experienced professional in patient advocacy and healthcare management, currently serving as the Head of Patient Advocacy at Intercept Pharmaceuticals since August 2022. Prior to this role, Marlene held the position of Associate Director, Patient Advocacy at Moderna from September 2021 to July 2022, and worked at bluebird bio as the Manager of Global Patient Advocacy from April 2016 to September 2021, where responsibilities included fostering relationships with rare disease organizations and collaborating with various internal teams. Marlene’s background also includes roles in commercial and marketing at Aegerion Pharmaceuticals, human capital management at GET Group Holdings Ltd., and consular affairs at multiple Mexican diplomatic missions. Marlene holds an International Master in Pharma and Health Management from Rome Business School and a degree in International Relations from Universidad Tecmilenio.